{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:25:36Z","timestamp":1787761536401,"version":"build-2784847793"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Ameloblastoma is a benign, locally aggressive neoplasm that needs extensive surgical resection. The goal of this article is to obtain an in-depth review of benign ameloblastomas to determine the available level of evidence and the possible benefit of targeted therapeutics for the treatment of ameloblastoma and BRAF V600E mutation in ameloblastoma. An electronic literature search was conducted according to PRISMA guidelines in PubMed\/MEDLINE, EBSCO, and Web of Science for eligible studies published between 1975 and 2021. The systematic review is registered with INPLASY (INPLASY202260018). The review included 2 case series and 17 case reports. The histopathological type, anatomic location, expression of BRAF mutation, additional mutations, and molecular-targeted therapies of the 19 reviewed articles were summarized and tabulated. Interestingly, the majority of the primary site of ameloblastoma was located in the mandible (80.9%) compared to the maxilla (17%). The tumour size was reported in nine of the included studies. Most of the included studies in the review exhibited ameloblastoma with BRAF V600E mutations and responded to molecular-targeted therapies. Molecular therapies employing BRAF and\/or MEK inhibitors in ameloblastoma with BRAF V600E mutations proved to be an appropriate treatment based on the limited available evidence. It is essential further to deepen our understanding at the clinical and molecular level to enhance the precision of management of ameloblastoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijdr.ijdr_456_22","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T08:41:37Z","timestamp":1673944897000},"page":"323-331","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Effectiveness of Molecular-Targeted Chemotherapy in Ameloblastomas"],"prefix":"10.4103","volume":"33","author":[{"given":"Thuckanaickenpalayam R.","family":"Yoithapprabhunath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenniyan K.","family":"Srichinthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diksha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Pasupuleti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramdas M.","family":"Nirmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20240828","doi-asserted-by":"crossref","first-page":"e0117241","DOI":"10.1371\/journal.pone.0117241","article-title":"Establishing the natural history and growth rate of ameloblastoma with implications for management: Systematic review and meta-analysis","volume":"10","author":"Chae","year":"2015","journal-title":"PLoS One"},{"key":"R2-20-20240828","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.4103\/JPBS.JPBS_57_19","article-title":"Meta-terminology of ameloblastoma","volume":"11","author":"Yoithapprabhunath","year":"2019","journal-title":"J Pharm Bioall Sci"},{"key":"R3-20-20240828","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-0035-1549012","article-title":"Management issues in the treatment of an ameloblastoma with an atypical presentation","volume":"8","author":"Larra\u00f1aga","year":"2015","journal-title":"craniomaxillofac Trauma Reconstr"},{"key":"R4-20-20240828","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.tripleo.2010.12.018","article-title":"Review of metastasizing (malignant) ameloblastoma (METAM): Pattern of metastasis and treatment","volume":"111","author":"Dissanayake","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R5-20-20240828","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/path.4317","article-title":"High frequency of BRAF V600E mutations in ameloblastoma","volume":"232","author":"Kurppa","year":"2014","journal-title":"J Pathol"},{"key":"R6-20-20240828","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R7-20-20240828","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1108\/07378830610692154","article-title":"A critical appraisal tool for library and information research","volume":"24","author":"Glynn","year":"2006","journal-title":"Libr Hi Tech"},{"key":"R8-20-20240828","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.joms.2010.05.084","article-title":"Metastasizing (malignant) ameloblastoma: Review of a unique histopathologic entity and report of Mayo Clinic experience","volume":"68","author":"Van Dam","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"R9-20-20240828","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/term.3254","article-title":"Upfront rational therapy in BRAF V600E mutated pediatric ameloblastoma promotes ad integrum mandibular regeneration","volume":"15","author":"Hirschhorn","year":"2021","journal-title":"J Tissue Eng Regen Med"},{"key":"R10-20-20240828","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000225058","article-title":"Ameloblastoma of the mandible with pulmonary metastasis","volume":"32","author":"Gall","year":"1975","journal-title":"Oncology"},{"key":"R11-20-20240828","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/00007611-198909000-00027","article-title":"Diagnosis and treatment of metastatic ameloblastoma","volume":"82","author":"Eliasson","year":"1989","journal-title":"South Med J"},{"key":"R12-20-20240828","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.oooo.2015.12.016","article-title":"BRAF inhibitor treatment of primary BRAF-mutant ameloblastoma with pathologic assessment of response","volume":"122","author":"Tan","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R13-20-20240828","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5582\/irdr.2017.01032","article-title":"Rare case of ameloblastoma with pulmonary metastases","volume":"6","author":"Valkadinov","year":"2017","journal-title":"Intractable Rare Dis Res"},{"key":"R14-20-20240828","first-page":"6793","article-title":"Mandible ameloblastoma with lung metastasis: A rare case report","volume":"8","author":"Yang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R15-20-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw190","article-title":"Durable treatment of ameloblastomawith single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma","volume":"109","author":"Faden","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"R16-20-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4802-y","article-title":"Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation","volume":"18","author":"Fernandes","year":"2018","journal-title":"BMC Cancer"},{"key":"R17-20-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.01204","article-title":"Enabling precision medicine for rare head and neck tumors: The example of BRAF\/MEK targeting in patients with metastatic ameloblastoma","volume":"9","author":"Brunet","year":"2019","journal-title":"Front Oncol"},{"key":"R18-20-20240828","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000226461","article-title":"Chemotherapy of Metastatic Ameloblastoma: A case report and review of the literature","volume":"44","author":"Lanham","year":"1987","journal-title":"Oncology"},{"key":"R19-20-20240828","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/1097-0142(19901001)66:7<1475::AID-CNCR2820660707>3.0.CO;2-D","article-title":"Pulmonary metastases from ameloblastoma of the mandible treated with cisplatin, adriamycin, and cyclophosphamide","volume":"66","author":"Ramadas","year":"1990","journal-title":"Cancer"},{"key":"R20-20-20240828","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/jnci\/dju378","article-title":"Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma","volume":"107","author":"Kaye","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R21-20-20240828","first-page":"1","article-title":"A case of recurrent metastatic ameloblastoma and hypercalcaemia successfully treated with carboplatin and paclitaxel: Long survival and prolonged stable disease","volume":"7","author":"Ghiam","year":"2013","journal-title":"Ecancermedicalscience"},{"key":"R22-20-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13256-019-2140-6","article-title":"Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: A case report","volume":"13","author":"Broudic-Guibert","year":"2019","journal-title":"J Med Case Rep"},{"key":"R23-20-20240828","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1023\/A:1012522929861","article-title":"Metastatic malignant ameloblastoma responding to chemotherapy with paclitaxel and carboplatin","volume":"12","author":"Grunwald","year":"2001","journal-title":"Ann Oncol"},{"key":"R24-20-20240828","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0266-4356(03)00046-9","article-title":"Metastatic pulmonary ameloblastoma: An unusual case","volume":"41","author":"Campbell","year":"2003","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R25-20-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-1947-5-491","article-title":"Metastatic ameloblastoma responding to combination chemotherapy: Case report and review of the literature","volume":"5","author":"Amzerin","year":"2011","journal-title":"J Med Case Rep"},{"key":"R26-20-20240828","first-page":"1","article-title":"MAID chemotherapy regimen as a treatment strategy for metastatic malignant ameloblastoma A case report","volume":"98","author":"Li","year":"2019","journal-title":"Medicine (Baltimore"},{"key":"R27-20-20240828","first-page":"60","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"Evid Based Med"},{"key":"R28-20-20240828","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.surge.2020.06.009","article-title":"Ameloblastoma: A succinct review of the classification, genetic understanding and novel molecular targeted therapies","volume":"19","author":"Shi","year":"2021","journal-title":"Surgeon"},{"key":"R29-20-20240828","first-page":"96","article-title":"Different treatment modalities for the management of ameloblastoma","volume":"4","author":"Bedi","year":"2016","journal-title":"J Adv Med Dent Sci Res"},{"key":"R30-20-20240828","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ijom.2019.04.008","article-title":"Risk factors for recurrence of ameloblastoma: A long-term follow-up retrospective study","volume":"48","author":"Au","year":"2019","journal-title":"Int J Oral Maxillofac Surg"}],"container-title":["Indian Journal of Dental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijdr.ijdr_456_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:00:21Z","timestamp":1787760021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijdr.ijdr_456_22"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijdr.ijdr_456_22","relation":{},"ISSN":["0970-9290"],"issn-type":[{"value":"0970-9290","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}